WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :

Download Article: Click Here

Search

Track Your Article

Abstract

GLIMPSES ON COVID-19 AND 2-DEOXY D-GLUCOSE AS A NOVEL APPROACH IN EMERGENCY TREATMENT: A REVIEW

Jerin James* and Soji S.

Abstract

Covid 19 is a highly infectious disease caused by severe acute respiratory syndrome coronavirus 2. It destructively spread all over the world. COVID-19 was identified in Wuhan City of China, on December 12th, 2019. Dr. Tedros Adhanom Ghebreyesus declared that the infection developed due to severe acute respiratory syndrome coronavirus 2 is “COVID-19” on February 11th, 2020. From the beginning, most treatment strategies were focused on symptomatic management and supportive therapy only. But now vaccines are also available. Recently, for emergency purposes, India's drug controller general has authorized “2-Deoxy-D-glucose” as an adjunct treatment. This review aims to provide some information about recently introduced 2-deoxy D-glucose. The lack of hydroxyl group at the second position makes this drug differ from glucose. It inhibits the living cell's glycolysis pathway and contains viral replication. As per the phase II clinical trial, it showed a positive outcome and reduced oxygen dependence. Now phase III is going on several hospitals across India. But studies showed some adverse effects also.

Keywords: Covid-19, 2-Deoxy-D-glucose, Glycolysis, Clinical trial, Adverse effect.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More